Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
---|---|---|---|---|---|---|---|---|---|
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 7.59% | 150 K | 77.52% | 4.63% | 2042-10-01 | 67.49 M USD | 1,000.00 USD | 2,000.00 USD | Actavis, Inc. |
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 7.40% | 15 K | 79.63% | 4.85% | 2044-06-15 | 65.23 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 7.28% | 10 K | 79.20% | 4.75% | 2045-03-15 | 53.51 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
AA5QDALLERGAN FNDG 15/25 | 7.19% | 0 | 99.25% | 3.80% | 2025-03-15 | 130.22 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 6.91% | 60 K | 85.86% | 4.55% | 2035-03-15 | 107.65 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049 | 6.08% | 7.88 M | 81.87% | 4.25% | 2049-11-21 | 5.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
US287YAW9ABBVIE 16/46 | 6.05% | 0 | 85.11% | 4.45% | 2046-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
4ABBABBVIE 15/45 | 5.94% | 0 | 88.59% | 4.70% | 2045-05-14 | 2.7 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042 | 5.90% | 2.3 M | 88.93% | 4.63% | 2042-10-01 | 389.22 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045 | 5.86% | 1.48 M | 89.70% | 4.75% | 2045-03-15 | 827.09 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042 | 5.86% | 935 K | 87.25% | 4.40% | 2042-11-06 | 2.6 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039 | 5.85% | 8.41 M | 85.67% | 4.05% | 2039-11-21 | 4 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048 | 5.84% | 1.7 M | 90.40% | 4.88% | 2048-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044 | 5.81% | 2.11 M | 91.21% | 4.85% | 2044-06-15 | 1.01 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064 | 5.81% | 4.27 M | 96.28% | 5.50% | 2064-03-15 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054 | 5.68% | 15.52 M | 96.89% | 5.40% | 2054-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044 | 5.62% | 1.68 M | 97.52% | 5.35% | 2044-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
US287YAV1ABBVIE 16/36 | 5.56% | 0 | 91.24% | 4.30% | 2036-05-14 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
US287YAR0ABBVIE 15/35 | 5.47% | 0 | 93.56% | 4.50% | 2035-05-14 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035 | 5.39% | 2.02 M | 94.48% | 4.55% | 2035-03-15 | 1.68 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034 | 5.19% | 10.13 M | 99.10% | 5.05% | 2034-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029 | 5.10% | 20 K | 92.50% | 3.20% | 2029-11-21 | 62.52 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029 | 5.05% | 9.88 M | 92.71% | 3.20% | 2029-11-21 | 5.44 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
4ABCABBVIE 15/25 | 4.99% | 0 | 99.47% | 3.60% | 2025-05-14 | 3.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031 | 4.98% | 4.02 M | 99.88% | 4.95% | 2031-03-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025 | 4.86% | 8.25 M | 99.76% | 3.80% | 2025-03-15 | 2.89 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029 | 4.85% | 3.42 M | 99.82% | 4.80% | 2029-03-15 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028 | 4.75% | 2.68 M | 98.37% | 4.25% | 2028-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
US287YAY5ABBVIE 16/26 | 4.67% | 0 | 98.08% | 3.20% | 2026-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026 | 4.63% | 2.53 M | 97.04% | 2.95% | 2026-11-21 | 3.99 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027 | 4.59% | 1.34 M | 100.43% | 4.80% | 2027-03-15 | 2.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
XS190919331ALLERGAN FNDG 18/28 | 4.11% | 0 | 95.03% | 2.63% | 2028-11-15 | 72.11 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS |
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026 | 3.86% | 0 | 96.53% | 2.95% | 2026-11-21 | 9.24 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
XXS162262122ALLERGAN FNDG 17/29 | 3.80% | 0 | 93.63% | 2.13% | 2029-06-01 | 36.46 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS |
4ABGABBVIE 19/31 | 3.02% | 0 | 89.91% | 1.25% | 2031-11-18 | 650 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. |
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025 | 3.01% | 0 | 102.15% | 3.80% | 2025-03-15 | 1.27 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049 | 2.90% | 0 | 121.31% | 4.25% | 2049-11-21 | 4.95 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045 | 2.88% | 0 | 126.76% | 4.75% | 2045-03-15 | 5 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044 | 2.83% | 0 | 128.71% | 4.85% | 2044-06-15 | 100 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
XS152090781ABBVIE 16/28 | 2.83% | 0 | 97.53% | 2.13% | 2028-11-17 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. |
XS212591483ABBVIE 20/28 | 2.76% | 0 | 99.54% | 2.63% | 2028-11-15 | 427.79 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. |
XS212591491ABBVIE 20/29 | 2.75% | 0 | 97.52% | 2.13% | 2029-06-01 | 506.09 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. |
4ABEABBVIE 19/27 | 2.65% | 0 | 94.87% | 0.75% | 2027-11-18 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. |
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035 | 2.35% | 0 | 123.74% | 4.55% | 2035-03-15 | 1 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042 | — | — | — | 4.40% | 2042-11-06 | 1.1 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025 | — | — | — | 3.80% | 2025-03-15 | — | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |